ArticleJournal of oncology2022

Effectiveness and Safety of Zercepac and Reference Trastuzumab in the Neoadjuvant Setting for Early-Stage Breast Cancer: A Retrospective Cohort Study.

Zheying Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.